Life Brand Acne Treatment Stick Recalled for Failed Assay
Oxygen Development LLC is recalling Life Brand Clear Action Acne Treatment Concealer Sticks because the salicylic acid content failed stability testing.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which is defined as unlikely to cause adverse health consequences. The issue is a failed assay (potency) rather than a contamination or acute safety hazard.
Plain-English summary
Oxygen Development LLC is recalling 12,216 units of Life Brand Clear Action Acne Treatment Concealer Stick (Salicylic acid), 1.9g. The product is identified by Lot # 060E and UPC 057800062653. It was imported for Shoppers Drug Mart Pharmaprix in Toronto, Canada.
The recall was initiated because the product is a superpotent drug that failed assay testing throughout the stick after six months of stability. This indicates the product did not meet the required potency standards over time.
Consumers who have purchased this specific lot should stop using the product and contact the retailer or manufacturer for instructions on return or disposal.
The recalled product
- Product
- Life Brand Clear Action Acne Treatment Concealer Stick (Salicylic acid), 1.9g, Imported for: Shoppers Drug Mart Pharmaprix Toronto, M2J4W8, UPC 057800062653
- Manufacturer
- Oxygen Development Llc
- Category
- Drug — Topical OTC
- Hazard
- Affected units
- 12,216
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: 060E
Distribution
Distribution scope not specified by the agency.
Related recalls
Other drug recalls
- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateLupin Recalls Clobetasol Propionate Cream for Content Uniformity Failures
FDA (Drugs) · 2026-09-02
- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02